Socio Today
The prevalence of Congenital Heart Disease (CHD), known locally as Penyakit Jantung Bawaan (PJB), remains a significant challenge for the Indonesian healthcare system, acting as the second leading cause of neonatal mortality in the country. While the exact etiology of CHD often remains elusive to medical science, healthcare experts are increasingly focusing on modifiable risk factors and early screening protocols to mitigate the impact of this condition. Dr. Rizky Adriansyah, a pediatric specialist and Chairman of the Cardiology Coordination Unit of the Indonesian Pediatric Society (IDAI), recently highlighted that while a definitive cause is often unknown, several environmental and physiological factors during pregnancy significantly elevate the risk of a child being born with a heart defect.
During a comprehensive webinar held on February 14, 2023, Dr. Rizky emphasized that the relationship between maternal health and CHD is not always a direct cause-and-effect scenario, but rather a complex interplay of risk factors. Current medical literature identifies three primary factors that demand immediate attention: maternal infections such as Rubella, nutritional deficiencies—specifically a lack of folic acid—and the consumption of certain medications, such as anti-seizure drugs, during the critical stages of fetal development. These factors can disrupt the intricate process of organogenesis, where the heart and its primary vessels are formed during the first trimester of pregnancy.
The Landscape of Congenital Heart Disease in Indonesia
The statistical burden of CHD in Indonesia is profound. Data from 2017 indicates that CHD accounts for approximately 17 percent of neonatal deaths, surpassed only by complications arising from prematurity. This aligns with global benchmarks set by the World Health Organization (WHO), which suggests that approximately one in every 100 newborns worldwide is affected by some form of CHD. Of these cases, an estimated 25 percent are classified as "critical CHD," a condition requiring immediate medical intervention or surgery within the first year of life to ensure survival. In the Indonesian context, this translates to roughly two to four critical cases per 1,000 live births.
Despite these figures, the treatment gap in Indonesia is stark. Dr. Rizky noted that fewer than 50 percent of CHD cases in the country are currently being managed or treated effectively. This disparity is attributed to a multifaceted crisis involving limited geographical access to specialized cardiac centers, a shortage of advanced diagnostic equipment in rural areas, and a critical deficiency in the number of pediatric cardiologists and thoracic surgeons. Furthermore, a general lack of public awareness regarding the early symptoms of CHD often leads to delayed diagnoses, which significantly worsens the prognosis for affected infants.
Identifying Maternal Risk Factors and Preventative Measures
Prevention remains the most effective strategy for reducing the incidence of CHD, particularly when the interventions occur prior to or during the early stages of pregnancy. Medical professionals stress that once a child is born with a heart defect, the window for primary prevention has closed, shifting the focus entirely to management and surgical correction.
The Rubella virus is one of the most well-documented teratogens—agents that cause birth defects. If a woman contracts Rubella during early pregnancy, the virus can cross the placenta and interfere with fetal development, leading to Congenital Rubella Syndrome (CRS), of which CHD is a primary component. Consequently, the IDAI and the Indonesian Ministry of Health strongly advocate for the Rubella vaccine as a cornerstone of pre-pregnancy healthcare. Ensuring that women of childbearing age are immune to the virus is a critical step in lowering national CHD rates.
Nutritional intervention is another pillar of prevention. Folic acid, a B-vitamin, is essential for DNA synthesis and cell division. A deficiency in this nutrient has long been linked to neural tube defects, but recent studies have increasingly solidified its role in preventing structural heart defects. Dr. Rizky advises that expectant mothers should not only maintain a diet rich in nutrients but also strictly adhere to folic acid supplementation as prescribed by healthcare providers.
Furthermore, the role of lifestyle factors cannot be ignored. While traditional risk factors such as maternal smoking and alcohol consumption are well-known to increase the likelihood of CHD, medical data reveals a more nuanced reality. Many cases of CHD occur in children whose mothers did not smoke or consume alcohol, suggesting that genetic predispositions and environmental pollutants may also play a role. However, avoiding tobacco and alcohol remains a fundamental recommendation for any healthy pregnancy.
Challenges in Early Detection and Diagnosis
The timing of a CHD diagnosis is often the deciding factor between life and death. Critical CHD is typically symptomatic within the first 24 to 48 hours of life or within the first week. However, many infants are discharged from birthing centers without being screened, only to return days later in a state of cardiovascular collapse.
One of the primary clinical indicators of CHD in infants is poor weight gain or "failure to thrive." Infants with heart defects often expend a significant amount of energy simply trying to breathe and circulate blood, leaving little caloric reserve for growth. Other symptoms include cyanosis (a bluish tint to the skin, lips, or fingernails), rapid breathing, and fatigue during feeding.
To combat the issue of late diagnosis, the medical community is promoting the use of pulse oximetry as a universal screening tool for newborns. This method is non-invasive, cost-effective, and highly sensitive. By placing sensors on the baby’s right hand and either foot, healthcare providers can measure the oxygen saturation levels in the blood. A significant discrepancy between the readings or an overall low saturation level can indicate the presence of a critical heart defect before the baby even shows outward symptoms.
Dr. Rizky also emphasized the importance of the "murmur" check. While not all heart murmurs are pathological, the presence of an abnormal sound during a stethoscope examination should immediately prompt further investigation, such as an echocardiography (an ultrasound of the heart). In Indonesia, the goal is to empower primary healthcare workers, including midwives in remote "Puskesmas" (community health centers), to perform these screenings. A pulse oximetry test takes less than five minutes but can be the difference-maker in a child’s survival.
Strengthening the Healthcare Infrastructure and Public Awareness
The high mortality rate associated with CHD in Indonesia is a reflection of systemic hurdles. The concentration of specialized cardiac facilities in major urban centers like Jakarta leaves families in remote provinces with limited options. The financial burden of cardiac surgery, which is among the most expensive medical procedures, also weighs heavily on the national health insurance system (BPJS Kesehatan) and individual families.
To address the awareness gap, the IDAI has turned to digital platforms. The YouTube channel "Sehatkan Jantung Anak Indonesia" serves as an educational hub, providing both parents and healthcare professionals with visual guides on how to detect early signs of heart distress and the steps required for a formal diagnosis. This initiative aims to democratize medical knowledge, ensuring that a parent in a remote village has the same access to life-saving information as a parent in a metropolitan area.
Implications and the Path Forward
The management of Congenital Heart Disease is not merely a medical issue but a socio-economic one. Every child born with an untreated heart defect represents a loss of potential human capital and an increased long-term burden on the healthcare system. By shifting the focus toward a "prevention and early detection" model, Indonesia can significantly reduce its neonatal mortality rate and improve the quality of life for thousands of children.
The way forward requires a three-pronged approach:
- Policy and Vaccination: Strengthening national immunization programs to ensure 100 percent Rubella vaccine coverage for young women.
- Institutional Capacity: Investing in the training of more pediatric cardiologists and distributing diagnostic tools like echocardiography machines more equitably across the archipelago.
- Community Empowerment: Integrating pulse oximetry into the standard newborn care package at all levels of the healthcare system and continuing aggressive public health education campaigns.
While the causes of CHD may remain partially shrouded in mystery, the path to reducing its impact is clear. Through a combination of maternal health vigilance, early neonatal screening, and improved medical access, the vision of "Sehatkan Jantung Anak Indonesia" can move from a digital slogan to a nationwide reality. The commitment of organizations like the IDAI, coupled with proactive government intervention, is essential to ensure that every Indonesian child is born with the best possible chance for a healthy heart and a long life.
